FATMA İLKNUR ÇINAR, Zeynep YILMAZ, NURTEN ÖZEN

Kemoterapi Tedavisi Devam Eden Meme Kanserli Hastalarda Kullanılan Tamamlayıcı Sağlık Yaklaşımları ve Etkileyen Faktörlerin Değerlendirilmesi

Amaç: Bu çalışmada, meme kanserli hastaların tamamlayıcı sağlık yaklaşımları kullanım durumları ve ilişkili faktörlerin araştırılması amaçlanmıştır. Yöntem: Çalışmaya bir eğitim ve araştırma hastanesinin onkoloji klinik/polikliniğinde takip edilen 71 meme kanseri hastası dâhil edildi. Çalışmaya katılmayı kabul eden hastaların sosyo-demografik, klinik özellikleri ve tamamlayıcı sağlık yaklaşımları kullanım durumları kaydedildi. Hastaların ilaç tedavisine inanç durumları “İlaçlar Hakkında İnançlar Anketi” ile değerlendirildi. Bulgular: Hastaların %21.1’i (n=15) bir tamamlayıcı sağlık yaklaşımları yöntemi kullandığını, kullananların tamamı, bu uygulamaların tıbbi tedavisine yararı olabileceğini düşündüğü için kullanmak istediğini, %9.9’u aile ve akrabaların tavsiyesi, %8.5’i medyanın etkisi nedeniyle tamamlayıcı sağlık yaklaşımları uygulamalarını kullandığını belirtti. Uzak organ tutulumu olan ve hastalık süresi daha uzun olan hastaların tamamlayıcı sağlık yaklaşımları uygulamalarını daha çok kullandıkları ve bunun istatistiksel olarak anlamlı olduğu bulundu (sırasıyla p=0.006, p=0.004). Tamamlayıcı sağlık yaklaşımları uygulamalarını kullanmayan hastaların ilaçların genel olarak zararlı olduğuna inandıkları (p=0.004) saptandı. Sonuç: Çalışmamızda hastaların yaklaşık beşte birinin başta doğal ürünler olmak üzere tamamlayıcı sağlık yaklaşımları uygulamalarından en az birini kullandıkları saptandı. Tamamlayıcı sağlık yaklaşımları uygulamalarını; uzak organ tutulumu ve hastalık süresi daha uzun olan hastaların daha çok, ilaçların daha çok zararlı olduğunu düşünen hastaların ise daha az kullandıkları tespit edildi.

The Evaluation of Complementary Health Approaches and Affecting Factors in Breast Cancer Patients with Ongoing Chemotherapy Treatment

Aim: The purpose of this study is to evaluate complementary health approaches and related factors in breast cancer patients. Methods: A total of 71 breast cancer patients who were followed-up at an oncology and outpatient clinic of a training and research hospital were included in the study. Sociodemographic characteristics, clinical characteristics, and the use of complementary health approaches were recorded for the patients who agreed to participate in the study. The patients’ beliefs about medicinal treatments were evaluated by the “Beliefs About Medicines Questionnaire.” Results: The patients reported that 21.1% of them (n=15) used a complementary health approaches method; all mentioned that they used it because they believed it may be beneficial for their medical treatment, 9.9% used it by taking into account the recommendation of family and relatives, and 8.5% used it due to the influence of the media. It was found that patients with distant organ metastasis and longer disease duration were more likely to use complementary health approaches, which is statistically significant (p= 0.006, p= 0.004, respectively). Patients who did not use complementary health approaches were found to believe that drugs are generally harmful (p= 0.004). Conclusion: In our study, it was determined that approximately one out of five patients used at least one of the complementary health approaches, particularly natural products. It was found that patients

PDF

___

1. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. Türkiye Kanser İstatistikleri. Ankara; 2018. Available from: https://hsgm.saglik.gov.tr/ depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2015. pdf
2. Özmen V. Breast cancer in Turkey: Clinical and histopathological characteristics (Analysis of 13.240 Patients). J Breast Health. 2014;10(2):98-105. doi: 10.5152/tjbh.2014.1988
3. Kalender ME, Buyukhatipoglu H, Balakan O, et al. Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. J Cancer Res Ther. 2014;10(4):962-6. doi: 10.4103/0973-1482.138010.
4. Kurt H, Keşkek ŞÖ, Çil T, Canataroğlu A. Meme kanserli hastalarda tamamlayıcı/alternatif tedavi kullanımı. Türk Onkoloji Dergisi. 2013;28(1):10-5. doi: 10.5505/tjoncol.2013.827.
5. Zulkipli AF, Islam T, Mohd Taib NA, et al. Use of complementary and alternative medicine among newly diagnosed breast cancer patients in Malaysia: An early report from the MYBCC study. Integr Cancer Ther. 2018;17(2):312-21. doi: 10.1177/1534735417745248.
6. National Center for Complementary and Integrative Health. National Institutes of Health. USA; 2018. Available from: https://nccih.nih.gov/ health/integrative-health
7. Sağlık Bakanlığından Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. T.C. Resmi Gazete; 2014 October 27. No. 29158. Available from: http://www.resmigazete.gov.tr/eskiler/2014/10/20141027-3.htm
8. Kang E, Yang EJ, Kim SM, et al. Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: A descriptive study. Supportive Care in Cancer. 2012;20(3):461-73. doi: 10.1007/s00520-011-1094-z.
9. Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide: The International Union Against Cancer survey. Cancer. 2001;91(7):1390-3. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/11283941
10. Lin YH, Chiu JH. Use of Chinese medicine by women with breast cancer: A nationwide cross-sectional study in Taiwan. Complement Ther Med. 2011;19(3):137-43. doi: 10.1016/j.ctim.2011.04.001.
11. Cui Y, Shu XO, Gao Y, et al. Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Research a n d T r e a t m e n t . 2 0 0 4 ; 8 5 ( 3 ) : 2 6 3 - 7 0 . d o i : 10.1023/B:BREA.0000025422.26148.8d.
12. Bebiş H, Akpunar D, Coşkun S, Özdemir S. Meme kanserli hastalarda tamamlayıcı ve alternatif tedavi kullanımı: literatür taraması. HEAD. 2014;11(2):6-14. Available from: https://www.journalagent.com/ kuhead/pdfs/KUHEAD_11_2_6_14.pdf
13. Akyol AD, Oz B. The use of complementary and alternative medicine by patients with cancer: In Turkey. Complement Ther Clin Pract. 2011;17(4):230-4. doi: 10.1016/j.ctcp.2010.12.003.
14. Tarhan MO, Muslu U, Somali I, et al. An analysis of the use of complementary and alternative therapies in patients with breast cancer. Breast Care. 2009;4(5):301-7. doi: 10.1159/000240988.
15. Mohd Mujar NM, Dahlui M, Emran NA, Abdul Hadi I, et al. Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia. PLoS One. 2017;12(4):e0176394. doi: 10.1371/journal. pone.0176394.
16. Chui PL, Abdullah KL, Wong LP, Taib NA. Quality of life in CAM and non-CAM users among breast cancer patients during chemotherapy in Malaysia. PLoS One. 2015;10(10):e0139952:1-17. doi: 10.1371/ journal.pone.0139952.
17. Cinar M, Cinar FI, Acikel C, et al. Reliability and validity of the Turkish translation of the beliefs about medicines questionnaire (BMQ-T) in patients with Behçet's disease. Clin Exp Rheumatol. 2016;34(6 Suppl 102):46-51. Available from: https://www.clinexprheumatol.org/ abstract.asp?a=10067
18. Molassiotis A, Scott JA, Kearney N, et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer. 2006;14(3):260-7. doi: 10.1007/s00520-005-0883-7.
19. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol & Health. 1999;14(1):1-24. doi: 10.1080/08870449908407311.
20. Sencan, H. Sosyal ve davranışsal ölçümlerde güvenilirlik ve geçerlilik. Ankara: Seçkin Yayıncılık; 2005.
21. Naja F, Fadel RA, Alameddine M, et al. Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: A cross-sectional study BMC Complement Altern Med. 2015;15(444):1-10. doi. 10.1186/s12906-015-0969-9.
22. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med. 2008;14(8):1049-55. doi: 10.1089/acm.2008.0039.
23. Can G, Demir M, Aydiner A. Complementary and alternative therapies used by Turkish breast cancer patients undergoing chemotherapy. Breast Care (Basel). 2012;7:471-5. doi: 10.1159/000345462.
24. Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat. 2006;100(2):219-27. doi: 10.1007/ s10549-006-9239-3.
25. Rakovitch E, Pignol JP, Chartier C, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat. 2005;90(2):139-48. doi: 10.1007/s10549-004-3779-1.
26. Nagel G, Hoyer H, Katenkamp D. Use of complementary and alternative medicine by patients with breast cancer: Observations from a healthcare survey. Support Care Cancer. 2004;12(11):789-96. doi: 10.1007/ s00520-004-0675-5.
27. Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer: A populationbased survey. Eur J Cancer. 2000;36(11):1359-64. doi: 10.1016/S0959-8049(00)00099-X.
28. Tas F, Ustuner Z, Can G, et al. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer p a t i e n t s . A c t a O n c o l . 2 0 0 5 ; 4 4 ( 2 ) : 1 6 1 - 7 . d o i : 10.1080/02841860510007549.
29. Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer. 2005;13(5):339-42. doi: 10.1007/s00520-004-0709-z.
30. Kim SH, Shin DW, Nam YS, et al. Expected and perceived efficacy of complementary and alternative medicine: A comparison views of patients with cancer and oncologists. Complementary Therapies in Medicine. 2016;28:29-36. doi: 10.1016/j.ctim.2016.07.005.

Koç Üniversitesi Hemşirelikte Eğitim ve Araştırma Dergisi-Cover

ISSN: 2618-5741
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 2004
Yayıncı: Koç Üniversitesi HYO Semahat Arsel Hemşirelik Eğitim ve Araştırma Merkezi (SANERC)